Dose Ranging Study in Healthy Methadone Maintenance Subjects

Status:
Completed

Trial end date:
2006-10-01

Target enrollment:

Participant gender:

To assess the effect of a single oral dose of MOA-728, an investigational drug, on the oral-cecal transit time in subjects who are taking methadone.

Phase 1

Bausch Health Americas, Inc.
Valeant Pharmaceuticals International, Inc.

Methadone